Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
Background Using vitamin K for correction of coagulopathy in critically ill patients is controversial with limited evidence. This study aims to evaluate the efficacy and safety of vitamin K in the correction of international normalized ratio (INR) elevation secondary to liver disease in critically i...
Guardado en:
Autores principales: | Khalid Al Sulaiman, Mashael Al Mutairi, Omar Al Harbi, Alanoud Al Duraihim, Sara Aldosary, Haifa Al Khalil, Abdulrahman Al Shaya, Shmeylan Al Harbi, Nouf Alotaibi, Kholoud Al Aamer, Ramesh Vishwakarma, Mohammed Al Asiri, Ohoud Aljuhani, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d4647e9cbd54c529725b3bec9aa442a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
por: Ohoud Aljuhani, et al.
Publicado: (2021) -
Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
por: Suad AlFadhli, et al.
Publicado: (2013)